Literature DB >> 22026586

Megakaryocytopoiesis and thrombopoiesis in hematopoietic stem cells exposed to ionizing radiation.

Satoru Monzen1, Emiko Tashiro, Ikuo Kashiwakura.   

Abstract

Hematopoietic processes, especially megakaryocytopoiesis and thrombopoiesis, are highly sensitive to extracellular oxidative stresses such as ionizing radiation and chemotherapeutic agents. This study examined the terminal maturation of megakaryocytes and platelet production in hematopoietic stem/progenitor cells (HSPCs) exposed to ionizing radiation. Highly purified CD34(+) cells derived from human placental/umbilical cord blood were exposed to X rays (2 Gy, 150 kVp, 20 mA; 0.5-mm aluminum and 0.3-mm copper filters) at a dose rate of approximately 1 Gy/min and then cultured in a serum-free medium supplemented with thrombopoietin and interleukin-3. The number of cells generated from X-irradiated CD34(+) cells decreased with the time in culture. However, the fraction of CD34(+)Tie-2(+) and CD41(+)Tie-2(+) cells among the total cells generated from X-irradiated cells increased significantly in comparison to nonirradiated controls on day 7. In addition, the CD42a(+) particles, which appeared to be platelets, generated from the X-irradiated HSPCs appeared to be normal. Quantitative real-time reverse transcriptase-polymerase chain reaction analysis of the expression of various genes in cells harvested from the cultures showed that the early hematopoiesis-related genes FLI1, HOXB4 and Tie-2, the cytokine receptor genes KIT and IL3RA, and the oxidative stress-related genes HO1 and NQO1 were upregulated on day 7. These results suggest that normal terminal maturation of megakaryocytes and platelet production occur in residual HSPCs after exposure to ionizing radiation despite the adverse effect of radiation on proliferation and differentiation of HSPCs. Ionizing radiation may have the potential to promote both megakaryocytopoiesis and thrombopoiesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22026586     DOI: 10.1667/rr2725.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

1.  Scorpion venom peptide SPVII promotes irradiated cells proliferation and increases the expression of the IL-3 receptor.

Authors:  Yifang Qiu; Liyuan Jiang; Caixia Wang; Yan Wang; Ting Li; Baiqian Xing; Meixun Zhou; Tianhan Kong; Weihua Dong
Journal:  Cell Biosci       Date:  2013-07-08       Impact factor: 7.133

2.  Cancer Stem Cells: Emergent Nature of Tumor Emergency.

Authors:  Yaroslav R Efremov; Anastasia S Proskurina; Ekaterina A Potter; Evgenia V Dolgova; Oksana V Efremova; Oleg S Taranov; Aleksandr A Ostanin; Elena R Chernykh; Nikolay A Kolchanov; Sergey S Bogachev
Journal:  Front Genet       Date:  2018-11-16       Impact factor: 4.599

3.  Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate.

Authors:  Katsumi Hirose; Satoru Monzen; Haruka Sato; Mariko Sato; Masahiko Aoki; Yoshiomi Hatayama; Hideo Kawaguchi; Yuichiro Narita; Yoshihiro Takai; Ikuo Kashiwakura
Journal:  J Radiat Res       Date:  2012-12-21       Impact factor: 2.724

4.  Characteristics of myeloid differentiation and maturation pathway derived from human hematopoietic stem cells exposed to different linear energy transfer radiation types.

Authors:  Satoru Monzen; Hironori Yoshino; Kiyomi Kasai-Eguchi; Ikuo Kashiwakura
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

5.  Involvement of placental/umbilical cord blood acid-base status and gas values on the radiosensitivity of human fetal/neonatal hematopoietic stem/progenitor cells.

Authors:  Masaru Yamaguchi; Satoko Ebina; Ikuo Kashiwakura
Journal:  J Radiat Res       Date:  2012-12-21       Impact factor: 2.724

6.  Thrombopoietin could protect cerebral tissue against ischemia-reperfusion injury by suppressing NF-κB and MMP-9 expression in rats.

Authors:  Wenjuan Wu; Wei Zhong; Bing Lang; Zhiping Hu; Jialin He; Xiangqi Tang
Journal:  Int J Med Sci       Date:  2018-08-10       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.